Bharat Parenterals Limited announced audited standalone and consolidated earnings results for the fourth quarter and full year ended March 31, 2021. For the quarter, on standalone basis, the company announced total income of INR 421.5 million compared to INR 559.6 million a year ago. Net profit was INR 19.6 million compared to INR 78.5 million a year ago. Basic earnings per share from continuing operations was INR 3.42 compared to INR 9.45 a year ago. For the full year, total income was INR 2,123.4 million compared to INR 2,378.1 million a year ago. Net income was INR 202.1 million compared to INR 263.0 million a year ago. Basic earnings per share from continuing operations was INR 35.27 compared to INR 45.90 a year ago. For the quarter, on consolidated basis, the company announced total income of INR 421.5 million compared to INR 568.3 million a year ago. Net profit was INR 18.9 million compared to INR 71.3 million a year ago. Basic earnings per share from continuing operations was INR 3.29 compared to INR 12.45 a year ago. For the full year, total income was INR 2,133.2 million compared to INR 2,396.6 million a year ago. Net income was INR 203.9 million compared to INR 241.4 million a year ago. Basic earnings per share from continuing operations was INR 35.59 compared to INR 42.14 a year ago.